PMID- 12417605 OWN - NLM STAT- MEDLINE DCOM- 20021112 LR - 20190513 IS - 0368-2811 (Print) IS - 0368-2811 (Linking) VI - 32 IP - 9 DP - 2002 Sep TI - A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism. PG - 368-70 AB - Three Japanese patients (a man and his two sons) in a family with clinical diagnosis of familial multiple endocrine neoplasia type 1 (MEN1) suffered from insulinoma(s), primary hyperparathyroidism and pituitary microadenoma. Genomic DNA of the patients was analyzed by sequencing for the MEN1 gene and an insertion of six nucleotides, CTGCAG, in exon 4, resulting in insertion of two amino acids, Leu-Gln, after the 256th amino acid of the menin (256insLQ), was identified. CTGCAG is a palindromic sequence and repeated twice in the wild-type allele (nucleotides 879-890). It is speculated that mutations involving only exon 4 of the MEN1 gene might induce development of insulinoma(s). FAU - Okamoto, Hiroomi AU - Okamoto H AD - Department of Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan. FAU - Tamada, Aiko AU - Tamada A FAU - Hai, Noritaka AU - Hai N FAU - Doi, Masaru AU - Doi M FAU - Uchimura, Isao AU - Uchimura I FAU - Hirata, Yukio AU - Hirata Y FAU - Kosugi, Shinji AU - Kosugi S LA - eng PT - Case Reports PT - Journal Article PL - England TA - Jpn J Clin Oncol JT - Japanese journal of clinical oncology JID - 0313225 RN - 0 (Nucleotides) SB - IM MH - Adult MH - Exons/genetics MH - *Germ-Line Mutation MH - Humans MH - Hyperparathyroidism/*genetics MH - Insulinoma/*genetics MH - Male MH - Middle Aged MH - Multiple Endocrine Neoplasia Type 1/*genetics MH - Nucleotides/genetics MH - Pancreatic Neoplasms/*genetics MH - Pedigree MH - Sequence Analysis, DNA EDAT- 2002/11/06 04:00 MHDA- 2002/11/26 04:00 CRDT- 2002/11/06 04:00 PHST- 2002/11/06 04:00 [pubmed] PHST- 2002/11/26 04:00 [medline] PHST- 2002/11/06 04:00 [entrez] AID - 10.1093/jjco/hyf079 [doi] PST - ppublish SO - Jpn J Clin Oncol. 2002 Sep;32(9):368-70. doi: 10.1093/jjco/hyf079.